AR
Aroa Biosurgery
ARX.NZ·NZXAuckland NZFounded 2008200 employees
Small CapbiotechPublicOncology
Platform: ECM
Market Cap
$0.4B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ARX.NZ)
Loading ARX.NZ stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ARX-3681 | ARX-3681 | Phase 2 | 2 | PD-1 | RA | ||
| Rimalucimab | ARX-134 | Phase 3 | 2 | FcRn | CTCL |
SEC Filings & Financial Documents
SEC filings are not available for NZX-listed companies.
Aroa Biosurgery trades on NZX (NZ). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)